↓ Skip to main content

Safety, tolerability, pharmacokinetics, and pharmacodynamics of PF-06650833, a selective interleukin-1 receptor-associated kinase 4 (IRAK4) inhibitor, in single and multiple ascending dose randomized…

Overview of attention for article published in Arthritis Research & Therapy, December 2019
Altmetric Badge

Citations

dimensions_citation
39 Dimensions

Readers on

mendeley
78 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Safety, tolerability, pharmacokinetics, and pharmacodynamics of PF-06650833, a selective interleukin-1 receptor-associated kinase 4 (IRAK4) inhibitor, in single and multiple ascending dose randomized phase 1 studies in healthy subjects
Published in
Arthritis Research & Therapy, December 2019
DOI 10.1186/s13075-019-2008-6
Pubmed ID
Authors

Spencer I. Danto, Negin Shojaee, Ravi Shankar P. Singh, Cheryl Li, Steven A. Gilbert, Zorayr Manukyan, Iain Kilty

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 78 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 78 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 11 14%
Researcher 8 10%
Student > Ph. D. Student 5 6%
Student > Postgraduate 5 6%
Student > Master 5 6%
Other 8 10%
Unknown 36 46%
Readers by discipline Count As %
Medicine and Dentistry 15 19%
Biochemistry, Genetics and Molecular Biology 6 8%
Nursing and Health Professions 5 6%
Agricultural and Biological Sciences 2 3%
Immunology and Microbiology 2 3%
Other 10 13%
Unknown 38 49%